Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in Relapsing-Remitting Multiple Sclerosis
NCT00095329Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 2003
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in multiple sclerosis (MS), sponsored by National Institute of Allergy and Infectious Diseases. Started May 2003; status: terminated.
02
Drugs
sirolimus
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00095329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095329.